Provision of DNA, Drug & Alcohol and Non-Invasive Prenatal Testing (NIPT)

Hull City Council, a sub-central government public authority, is seeking tenders for the provision of DNA, Drug & Alcohol, and Non-Invasive Prenatal Testing (NIPT) services. This tender, identified as LP/25, falls under the services category and is open to competition using a below-threshold method. The procurement is divided into three lots, with the contract expected to start on 1st April 2026 and conclude by 31st March 2029, featuring an optional one-year extension.

The procurement process is currently at the tender stage, with a closing date for submissions on 19th December 2025. The procurement is set to be conducted in the region of Hull, United Kingdom, and targets the healthcare sector specifically engaging with medical laboratories. This tender provides a substantial opportunity for businesses in the medical testing industry, particularly those specialising in DNA, drug and alcohol, and prenatal testing.

With an estimated annual service value of £108,380, small and medium enterprises, as well as voluntary and community sector enterprises, are encouraged to participate due to the tender’s compatibility with a wide range of organisational sizes. The structure of the tender, split into three lots, offers multiple opportunities for businesses to secure contracts, each allowing up to three suppliers per lot on a rotational direct award basis. Businesses demonstrating strong relevant experience, robust delivery methodologies, and best practice in training and safeguarding stand a good chance of securing a place, alongside competitive pricing.

The inclusion of social value in the award criteria highlights an opportunity for businesses committed to contributing positively to the community.